✨ Your Portfolio is fetched and updated from zerodha.
Large Pharmaceuticals
Market Cap
₹1,05,003 Cr.
P/E
51.44
About
Mankind Pharma Limited is a company involved in the development, manufacturing, and marketing of pharmaceutical formulations across various therapeutic areas, along with consumer healthcare products i… Read more
Mankind Pharma Limited is a company involved in the development, manufacturing, and marketing … Read more
Low
1901
52W Range
High
3055
  • Mankind Pharma
  • Dr. Reddy's Lab
  • Torrent Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

3 Neutral

Neutral for this company

5 No

Negative for this company

1 No Data

Insufficient data to analyse

Market Share
0 %
(as of Mar 22)
Anti Fungal Antibiotics (Terbinaforce) - Market Share
0 %
(as of Mar 22)
Anti-Hypertensives (Amolkind-AT) Market Share
60 %
(as of Jun 23)
Birth Control (Unwanted-72) - Market Share
0 %
(as of Mar 21)
Depression (Placida) - Market Share
0 %
(as of Mar 21)
Gastrointestinal (Nurokind-LC) - Market Share
Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Location Wise Break-Up - Domestic Sales

Acute vs Chronic

Brand Wise Break-Up

Operational Metrics

    Select a Metric
    • Number of ANDA's Filed in USA (.)
    • Number of ANDA's Approved By USFDA (.)
    • Advertisement Spend as a % of Total Sales (%)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Acne Star
    Manforce
    Preganews
    Unwanted72
    FAQs on Mankind Pharma Ltd. Business

    Mankind Pharma Limited is an Indian company specializing in pharmaceutical formulations and consumer healthcare products. It emphasizes quality offerings at affordable prices, successfully building several in-house brands.

    Mankind Pharma major competitors are Torrent Pharma, Dr. Reddy's Lab, Lupin, Cipla, Zydus Lifesciences, Aurobindo Pharma, Abbott India.
    Market Cap of Mankind Pharma is ₹1,05,003 Crs.
    While the median market cap of its peers are ₹95,370 Crs.

    Mankind Pharma seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Sep Dec Jan Mar Jun Sep Dec
    Conference Call Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Mankind Pharma Ltd.
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material